91桃色

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Cancer hallmarks and multiscale simulation in medicine

Pharma Middle East

Ales Prokop

Vanderbilt University, USA

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
The original list of hallmarks includes self-sufficiency in growth signals, insensitivity to anti-growth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis and tissue invasion and metastasis. This list has been recently extended from 6 to 10 with few more hallmarks emerging. In this paper, we concentrate on the second one (p53/microRNA-34a network in natural and therapeutic tumor suppression setting). Solving problems in system biology requires various approaches ranging from molecular processes up to the macro-organism, thus requires special attitude to handle these problems mathematically. The problem is widely different time scales at different levels of organization from molecules to macro-organism. Oncologic diseases are typical examples. Although there is an obvious progress in knowledge and treatment, the numbers of positively diagnosed patients are growing. As the oncologic diseases do not represent a single illness but a heterogeneous class of disorders with various causality and consequences, the quest for common attributes or effective prevention and therapy is a highly complicated task. Recent empiric procedures are frequently failing and leading only to suppression of symptoms. Similarly, our knowledge on prevention is coming from epidemiological studies based on previous observations. Meta-analysis of available data can help to identify some unexpected and therefore unattended interactions. Systemic analysis using simulated experiments and subsequent experimental (wet lab) verification may serve as a tool to search for complex therapeutic procedures. Understanding of malignant processes and their modeling will open new possibilities for more exact prediction of preventive or therapeutic approaches. The simulation of cancer should be considered as additional tool in the battlefield of war on cancer.
Biography

Email: ales.prokop@vanderbilt.edu

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top